Dissolution test for lamivudine tablets: Optimization and statistical analysis

被引:10
作者
Fernandes, Christian
Junqueira, Roberto Goncalves
Moreira Campos, Ligia Maria
Pianetti, Gerson Antonio
机构
[1] Univ Fed Minas Gerais, Fac Farm, Dept Prod Farmaceut, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Farm, Dept Alimentos, BR-31270901 Belo Horizonte, MG, Brazil
关键词
lamivudine; dissolution test; generic drug; Duncan test; anti-HIV drugs;
D O I
10.1016/j.jpba.2006.05.009
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A comparison of different methods for dissolution test used by five different manufacturer laboratories of lamivudine tablets is made, evaluated, and discussed. Dissolution medium (water and hydrochloric acid pH 1.2), apparatus (paddles and baskets) and time (30 and 60 min) were analyzed. The determination was accomplished by spectrophotometry at 270 nm. Analysis of variance (ANOVA) factorial design 5 x 2 x 2 x 2 with six repetitions, with post hoc multiple comparisons between means conducted by Duncan test at 0.05 significance level was used. After the comparative analysis of the results, optimal dissolution conditions were determined as follows: water as dissolution medium, paddles at the stirring speed of 50 rpm as apparatus and time of 30 min. The method was applied to the dissolution test of samples from eleven batches of tablets, produced by five different laboratories. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:601 / 606
页数:6
相关论文
共 19 条
[1]   Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase [J].
Anderson, KS .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :296-299
[2]  
[Anonymous], PROP WAIV IN VIV BIO
[3]  
[Anonymous], 2005, INT C HARM VAL AN PR
[4]  
[Anonymous], 1983, Statistical methods
[5]  
Banker GS, 1986, THEORY PRACTICE IND
[6]  
*BRAZ HLTH MIN, 2005, POL AIDS DRUGS HLTH
[7]  
*BRAZ HLTH MIN, 2005, DOC REC TECHN REP
[8]  
*BRAZ NAT AG SAN V, 2005, LIST REF DRUGS
[9]   New developments in anti-HIV chemotherapy [J].
De Clercq, E .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :258-275
[10]  
FDA U., 1997, GUID IND DISS TEST I